A settlement has been reached regarding allegations of overbilling Medicaid for insulin. CVS will pay $36.5 million to resolve the matter. The allegations stem from the period between 2010 and 2020.

During this time, it is claimed that CVS dispensed excessive amounts of insulin to patients. Further details on the settlement and allegations are available from the attorney general and news outlets, including KHOU Houston.